How Much Does Metoprolol Raise Blood Sugar?

For most people, metoprolol nudges blood sugar up only a little. The more meaningful concern isn’t a jump in today’s reading but a gradual, modest rise in the odds of developing diabetes over years.1PubMed Central. Effects of metoprolol and carvedilol on pre‐existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET) How big the effect is depends partly on how much you take and what other blood pressure pills it’s paired with. For most people the heart benefit outweighs the sugar effect, and stopping it on your own isn’t the answer.

How Much Metoprolol Changes Blood Sugar and A1c

A1c (HbA1c) is the number on your lab report that shows your average blood sugar over about three months, which makes it the best measure of a drug’s effect. In people with type 2 diabetes and high blood pressure, metoprolol raised A1c by about 0.15 percentage points over several months.2JAMA. Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension: A Randomized Controlled Trial An A1c of 7.0% might drift to around 7.15%, a change smaller than ordinary month-to-month variation. Carvedilol, another beta-blocker, left A1c essentially unchanged in the same comparison.3JAMA. Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension: A Randomized Controlled Trial

In people with high blood pressure but no diabetes, metoprolol caused a small but real rise in fasting blood sugar.4PubMed. Influence of beta-blocking drugs on glucose metabolism in hypertensive, non-diabetic patients Longer-term use nudged up fasting glucose, fasting insulin and A1c together.5PubMed Central. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients So a slightly higher fasting reading after you start metoprolol may be the drug, not a sign that something else is wrong.

On your own meter, a few extra points on a fasting fingerstick fits with metoprolol. A large jump, such as fasting readings well above your usual range, is more likely to have another cause, like diet, illness or a steroid medicine. Telling your prescriber about any other medicine started around the same time helps sort out which one is responsible. The fair comparison is a run of readings from before you started against a run from a few months in, not single days.

Single readings tell you little because fingerstick and lab numbers swing with meals, sleep, stress and illness. A1c averages roughly three months, so it won’t fully reflect a new drug until about that long after you start.

A1c and fasting glucose measure different things. A1c reflects average sugar over weeks, including after meals, while a fasting reading is one snapshot after a night without food. The two can move by different amounts, so a small rise in one with no change in the other isn’t unusual. If your doctor orders both, looking at them together gives a more reliable picture.

A small shift can still matter to some people. Someone sitting just under the prediabetes or diabetes cutoff can be tipped over the line, and people already near their A1c target may need a small adjustment to their diabetes plan. For most others the change is too small to alter treatment.

Why Metoprolol Pushes Blood Sugar Up

Insulin sensitivity is how well your muscles and liver respond to insulin by pulling sugar out of the blood. On metoprolol, the amount of sugar insulin moved into tissues fell by about a fifth.6PubMed Central. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients After 12 weeks in people with metabolic syndrome, metoprolol lowered insulin sensitivity while nebivolol, another beta-blocker, did not.7PubMed Central. Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome

The adrenaline-type signals that beta-blockers block also help the pancreas release insulin.8Picmonic. Systemic Effects of Beta-Blockers Blocking them can trim insulin release, as seen in lab studies.9PubMed. Effects of beta-blocking agents on insulin secretion and glucose disposal Less insulin and a weaker response together explain the modest sugar rise.

Most people’s pancreas can compensate, so the effect usually shows up as a small drift in numbers rather than sudden high sugar. Extra insulin can hide the effect from a glucose meter. A body already struggling to keep sugar down has less spare capacity to make up the difference. That’s why the same drug can change numbers visibly in one person and barely at all in another.

Weight plays a part too. Beta-blockers can come with small weight gain, which itself worsens insulin response. Staying active helps offset the effect, because exercise improves how well your body responds to insulin.

Higher Doses Have a Bigger Effect

Metoprolol is heart-focused: at low doses it mainly blocks receptors in the heart. Beta receptors are docking points for adrenaline-type signals, and they sit in different organs, including the heart, lungs, blood vessels and muscle. As doses rise, metoprolol gradually blocks other receptors too, including ones involved in sugar control.10PubMed. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial In heart failure patients this loss of selectivity showed up at 100 mg a day or more.11PubMed Central. Effects of Beta-Blocker Titration on Glucose Homeostasis in Heart Failure So someone on 25 to 50 mg is likely to see less sugar effect than someone on 200 mg.

Higher doses aren’t always avoidable. Heart failure and certain rhythm problems are treated with doses raised step by step toward a target, and there the benefit of reaching the right dose usually outweighs a small extra sugar effect. The practical move is to watch your numbers as the dose rises, not to hold back on your own.

It’s reasonable to ask your doctor whether the lowest dose that controls your heart rate or pressure is enough. You can also ask whether tartrate twice daily or succinate extended-release changes your total daily amount. Never change the dose yourself, because sudden changes can strain the heart.

Does Metoprolol Cause Diabetes

In a large heart failure trial, about 12.6% of people on metoprolol developed diabetes versus 10.3% on carvedilol over several years.12PubMed Central. Effects of metoprolol and carvedilol on pre‐existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET) That works out to roughly 2 more people in every 100 on metoprolol. A nationwide Danish study of heart failure patients found carvedilol users had about 17% lower risk of new type 2 diabetes than metoprolol users.13PubMed Central. Long‐Term Mortality Associated With Use of Carvedilol Versus Metoprolol in Heart Failure Patients With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study Yet in older adults who already had diabetes and heart failure, metoprolol users needed new diabetes medicines no more often than carvedilol users.14PubMed Central. Risk of clinically relevant hyperglycemia with metoprolol compared to carvedilol in older adults with heart failure and diabetes

These figures come from comparing two drugs, not metoprolol against no treatment. Most people on metoprolol in those studies did not develop diabetes, and the gap is too small to predict anything about any one person.

The studies seem to disagree because they ask different questions. The one in older adults asked whether people with diabetes needed new medicine, not whether diabetes appeared. Taken together, the fair reading is a modest risk of new diabetes, with little evidence that existing diabetes becomes much harder to manage.

People with prediabetes, overweight or a family history start closer to the line, and the drug adds a small push rather than causing diabetes from nothing. Metoprolol prevents heart attacks and helps failing hearts, benefits much larger than the sugar risk.

Combining a beta-blocker with a thiazide diuretic such as hydrochlorothiazide raises the chance of developing diabetes more than regimens that avoid the pair.15PubMed. The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension Thiazide-type pills can raise blood sugar on their own, so the two drugs can add up. Don’t stop either one yourself, since both are controlling blood pressure. If you’re on both and have prediabetes, ask at your next visit whether a different combination would control your pressure with less sugar effect.

Metoprolol and Low Blood Sugar on Insulin

Metoprolol blocks the fast heartbeat that normally signals a low.16PubMed. Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects A pounding heart during a low comes from adrenaline acting on heart receptors, exactly what the drug blocks. Sweating works through a different pathway, and it actually increased during lows on metoprolol while other symptoms were unchanged.17PubMed. Effects of metoprolol on the counter-regulation and recognition of prolonged hypoglycemia in insulin-dependent diabetics In insulin users with high blood pressure, the other warning signs of lows were not masked.18PubMed. Effect of metoprolol and alprenolol on the metabolic, hormonal, and haemodynamic response to insulin-induced hypoglycaemia in hypertensive, insulin-dependent diabetics Hunger, shakiness, a tingling mouth and sudden irritability or confusion still come through, so learn which ones you get.

Recovery can be slower. At 100 mg, metoprolol slowed the return of blood sugar to normal after a low in people with type 1 diabetes.19PubMed. Oral propranolol and metoprolol both impair glucose recovery from insulin-induced hypoglycemia in insulin-dependent diabetes mellitus It slowed recovery less than propranolol, an older non-selective beta-blocker.20PubMed. Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics Beta-blockade can reduce the body’s own adrenaline-driven push to bring sugar back up, so a low may take longer to resolve by itself. Treat it with fast-acting sugar such as glucose tablets or juice, recheck in 15 minutes, and repeat the fast sugar if you’re still low.

If you use insulin, check your sugar more often in the first weeks after starting metoprolol or raising the dose. Carry fast-acting glucose and tell family that your heart may not race during a low. If lows are frequent, a continuous glucose monitor with alerts is worth considering.

Beta-Blockers That Affect Blood Sugar Less

Carvedilol left A1c unchanged where metoprolol raised it.21JAMA. Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension: A Randomized Controlled Trial Nebivolol did not reduce insulin response either.22PubMed Central. Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome Atenolol, another heart-focused beta-blocker, lowered insulin response similarly to metoprolol,23PubMed Central. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients so being heart-focused alone doesn’t guarantee a gentler sugar effect. If sugar control is a concern, ask whether carvedilol or nebivolol fits your heart condition.

Carvedilol blocks both beta and alpha receptors, and the alpha effect widens blood vessels, which may be part of why it’s kinder to insulin response. Nebivolol is heart-focused but also relaxes blood vessels, something metoprolol doesn’t do.

Switching isn’t automatic. Not every beta-blocker is approved or proven for every heart condition. Carvedilol lowers blood pressure more and can cause dizziness, and cost and dosing schedules differ. A prescriber would typically start the new drug at a low dose and adjust it while tapering metoprolol rather than stopping it outright. Heart rate and blood pressure are usually checked during the changeover. Because the benefit is small, a switch is mostly worth discussing if you have prediabetes, diabetes, or numbers that are already hard to control.

Cholesterol Changes Alongside Blood Sugar

Over 6 to 12 months metoprolol raised triglycerides and lowered HDL cholesterol.24PubMed. Effects of long-term treatment with metoprolol and hydrochlorothiazide on plasma lipids and lipoproteins In people with diabetes and high blood pressure, it did the same.25PubMed. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients Carvedilol left triglycerides unchanged where extended-release metoprolol raised them.26PubMed. Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: results of the Extended-Release Carvedilol Lipid Trial

High triglycerides and low HDL often travel with insulin resistance, so these changes fit the same pattern as the sugar effect. Together they can add to cardiovascular risk over time, which is why they’re worth tracking even though the shifts are modest. They show up on a standard lipid panel, so no extra test is usually needed.

A modest triglyceride rise after starting may be the drug. Cutting sugary drinks and alcohol lowers triglycerides, and it’s better to mention changes at your next check than to stop the medicine. Triglycerides also swing with a recent meal, alcohol and weight changes, so a fasting sample gives a fairer comparison.

Will Blood Sugar Return to Normal If You Stop

Sugar rises caused by heart drugs can sometimes reverse after the drug is stopped.27PubMed. The impact of cardiovascular drugs on hyperglycemia and diabetes: a review of ‘unspoken’ side effects But stopping a beta-blocker suddenly can trigger a fast heart rate, chest pain or heart attack, so any change should be tapered under your doctor’s guidance. For many people metoprolol is protecting the heart after a heart attack, controlling rhythm or supporting heart failure, and those jobs are hard to replace quickly. If the sugar effect worries you, the question to raise is whether another drug can do the same heart job.

If metoprolol is tapered or swapped, sugar numbers may drift back toward your earlier baseline over weeks to months, not overnight. Reversal isn’t guaranteed, especially if weight gain or other factors have contributed in the meantime. A1c needs about three months to show the full picture, so judging too early can mislead.

While you’re on metoprolol, get an A1c and fasting glucose before starting if possible, as a baseline. Recheck A1c about three months after starting or after a dose increase. Keep activity, weight and diet steady so changes can be attributed fairly, and bring your meter log to appointments.